Skip to main content

Table 2 Laboratory parameters before and after treatment with DAAs

From: Safety and efficacy of direct-acting antiviral drugs in the treatment of chronic hepatitis C virus infection in patients with thalassemia: a prospective study

Parameter Before After Statistic P value
ALT(IU/ml) 57.29 ± 35.07 42.4545 ± 18.56 3.569 0.0005
S. bilirubin ( mg/dL) 3.17 ± 1.08 2.51 ± 1.06 4.800 0.0005
Hemoglobin (g/dL) 8.5 ± 1.34 8.64 ± 1.38 − 0.513 0.613
Platelets count (× 109/L) 513.18 ± 160.47 460.14 ± 186.81 1.764 0.092
WBCs (×109/L) 27.30 (18.27–51) 20.50 (12.15–49) − 1.072 0.284
  1. Data presented as mean ± SD except WBCs presented as median (IQR). For WBCs, data were not normally distributed (Shapiro test, p < 0.05) with the presence of significant outliers. Accordingly, Wilcoxon test was conducted. Paired samples t test was used for other parameters as the data were normally distributed